Cannabix Chief Scientific Officer Presents Multi-Drug Breath Testing in Vancouver on November 13: The Platform Detected THC, Amphetamines, Cocaine and Opioids Such as Fentanyl
Breath testing technology company Cannabix Technologies announced on November 13, 2026 that its chief scientific officer, Dr. Raj Attariwala, would present the company's emerging multi-drug breath testing technology at the BC Centre for Excellence conference on substance use disorder, held in Vancouver, British Columbia on November 13. The company said recent findings demonstrate the ability of its Multi-Drug Breath Test platform to detect delta-9 THC and other illicit drugs in breath, including traces of amphetamines and methamphetamines, cocaine, and opioids such as fentanyl. The company said the findings highlight the broader potential of its Breath Collection Unit platform as a standardized breath collection technology that could support future multi-analyte testing approaches and scientific breath initiatives. Company information describes Cannabix as a developer of breath-based technologies for workplaces, law enforcement and other settings, including a marijuana breath test targeting delta-9 THC and the BreathLogix unmanned alcohol screening solution.
(Source: Cannabix Technologies)
Source: Cannabix Technologies
Published by GSM · USA (original Chinese edition)
Photo: 图：执法人员进行呼气酒精检测。Oregon Department of Transportation，CC BY 2.0，经 Wikimedia Commons。 / Photo: Oregon Department of Transportation, CC BY 2.0, via Wikimedia Commons.
Silicon Carbide Nanomaterials in Disc Brake Pads: 0.5% Loading Raised Average Brake Force by Up to 19%, With Fade Resistance Up to 130°C2026-11-14
PEBA-PEMA Blend Membrane Separates 1-Butanol With Flux of 0.19 kg/m2/h and Separation Factor of 15.5 at 5 Percent PEMA, Published in Scientific Reports on November 132026-11-14